Downstreamthe daily issueevery agency

Drug Enforcement Administration

37 documents across 9 days of the archive, 4 of them final rules. The five most recent days are below.

Dates this agency has set that have not yet arrived

What is in this list

Comment deadlines and effective dates from anything this agency published in the archive, still ahead of 11 September 2026.

Dates set before this archive began are not here, and their absence is not evidence that none exist.

as_of

  1. +13d Comments close Importer of Controlled Substances Application: Chattem Chemicals Justice Department · Drug Enforcement Administration
  2. +13d Comments close Importer of Controlled Substances Application: Prof Compounding CTS of Ameri Justice Department · Drug Enforcement Administration
  3. +13d Comments close Importer of Controlled Substances Application: Galephar Pharmaceutical Research Inc. Justice Department · Drug Enforcement Administration
  4. +13d Comments close Importer of Controlled Substances Application: Vici Health Sciences, LLC Justice Department · Drug Enforcement Administration
  5. +13d Comments close Importer of Controlled Substances Application: Biopharmaceutical Research Company Justice Department · Drug Enforcement Administration
  6. +14d Comments close Importer of Controlled Substances Application: Curia New York Inc. Justice Department · Drug Enforcement Administration
  7. +14d Comments close Importer of Controlled Substances Application: Experic LLC Justice Department · Drug Enforcement Administration
  8. +14d Comments close Importer of Controlled Substances Application: Cambrex Charles City Justice Department · Drug Enforcement Administration
  9. +17d Comments close Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV Justice Department · Drug Enforcement Administration
  10. +27d Comments close Importer of Controlled Substances Application: Fisher Clinical Services, Inc. Justice Department · Drug Enforcement Administration
  11. +27d Comments close Importer of Controlled Substances Application: Cambrex High Point, Inc. Justice Department · Drug Enforcement Administration
  12. +27d Comments close Importer of Controlled Substances Application: Fresenius Kabi USA, LLC Justice Department · Drug Enforcement Administration
  13. +27d Comments close Importer of Controlled Substances Application: AndersonBrecon, Inc DBA PCI Pharma Services Justice Department · Drug Enforcement Administration
  14. +32d Comments close Exempt Chemical Preparations Under the Controlled Substances Act Justice Department · Drug Enforcement Administration
  15. +45d Comments close Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC Justice Department · Drug Enforcement Administration
  16. +45d Comments close Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals Justice Department · Drug Enforcement Administration
  17. +45d Comments close Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute SRI Montana Satellite Laboratory Justice Department · Drug Enforcement Administration
  18. +45d Comments close Bulk Manufacturer of Controlled Substances Application: Curia Missouri Inc. Justice Department · Drug Enforcement Administration
  19. +45d Comments close Bulk Manufacturer of Controlled Substances Application: Curia New York Inc Justice Department · Drug Enforcement Administration
  20. +45d Comments close Bulk Manufacturer of Controlled Substances Application: Biopharmaceutical Research Company Justice Department · Drug Enforcement Administration
  21. +45d Comments close Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City Justice Department · Drug Enforcement Administration
  22. +45d Comments close Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC Justice Department · Drug Enforcement Administration
  23. +59d Comments close Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc. Justice Department · Drug Enforcement Administration

11 September 2026 4 documents

Machine-written from the fields above · claude-haiku-4-5-20251001

The Drug Enforcement Administration published four Decision and Order notices regarding Emran Mohammad, Joseph John Stubbers III, Cheryl White, and Craig Cohen.

Post on X Post on LinkedIn Permalink

8 September 2026 7 documents

Machine-written from the fields above · claude-haiku-4-5-20251001

The Drug Enforcement Administration published seven notices on controlled substance registrations and practitioner actions.

Post on X Post on LinkedIn Permalink

28 August 2026 3 documents

Machine-written from the fields above · claude-haiku-4-5-20251001

The Drug Enforcement Administration published three decision and order notices regarding Atlantic Treatment Center, Thomas Earley, and Leila Kump.

Post on X Post on LinkedIn Permalink

27 August 2026 2 documents

Machine-written from the fields above · claude-haiku-4-5-20251001

The Drug Enforcement Administration placed cipepofol in Schedule IV and temporarily placed four synthetic opioid analogues in Schedule I of the Controlled Substances Act.

Post on X Post on LinkedIn Permalink

RuleJustice DepartmentDrug Enforcement Administration

Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV

On May 29, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Cypsedo (cipepofol) for induction of general anesthesia in adults undergoing surgery. The Department of Health and Human Services provided the Drug Enforcement Administration (DEA) with a scheduling recommendation to place cipepofol, chemically known as 2-[(1R)-1-cyclopropylethyl]-6- isopropylphenol, in schedule IV of the Controlled Substances Act (CSA). In accordance with the CSA, as amended by the Improving Regulatory Transparency for New Medical Therapies Act, DEA is hereby issuing an interim final rule placing cipepofol in schedule IV of the CSA.

  • Comments close in 17 days
  • Takes effect 15 days ago

91 FR 55259FR Doc. 2026-17536official PDFfederalregister.gov

RuleJustice DepartmentDrug Enforcement Administration

Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act

The Drug Enforcement Administration (DEA) issues this temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4- yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro brorphine or SR-14968); 5,6-dichloro-1-(1-(4- chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro desmethylchlorphine or SR-17018); 3-(3- (1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H- benzo[d]imidazol-1-yl)propanenitrile (commonly known as N-propionitrile chlorphine or cychlorphine); and 8-(1-(4-chlorophenyl)ethyl)-1-phenyl- 1,3,8-triazaspiro[4.5]decan-4-one (commonly known as spirochlorphine or R-6890), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible, to schedule I under the Controlled Substances Act. DEA bases this action on a finding that placing 5,6-dichloro brorphine, 5,6-dichloro desmethylchlorphine, N- propionitrile chlorphine, and spirochlorphine in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these substances.

  • Takes effect 15 days ago

91 FR 55252FR Doc. 2026-17531official PDFfederalregister.gov

26 August 2026 6 documents

Machine-written from the fields above · claude-haiku-4-5-20251001

The DEA temporarily placed mitragynine pseudoindoxyl, MGM-15, and MGM-16 in Schedule I of the Controlled Substances Act.

Post on X Post on LinkedIn Permalink

RuleJustice DepartmentDrug Enforcement Administration

Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I

The Drug Enforcement Administration (DEA) is issuing this temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing mitragynine pseudoindoxyl, MGM-15, and MGM-16 in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these three 7-hydroxymitragynine-related substances.

  • Takes effect 16 days ago

91 FR 54948FR Doc. 2026-17429official PDFfederalregister.gov

Earlier

4 further days of this agency's activity are in the long-form archive, oldest to newest, on one page.

Everything Drug Enforcement Administration has published, 2026-08-11 to 2026-09-11 →

Ask an assistant instead

Everything on this page is also a tool call. Add mcp.downstream.sh as an MCP server in Claude, ChatGPT, or any client that speaks the protocol — no key, no account — then paste this:

Using the Downstream MCP server at mcp.downstream.sh, call whats_new_since with agency "Drug Enforcement Administration" since 2026-08-26, then summarise what changed and list every deadline it created.

Reaches whats_new_since. The response carries its own citations and states what it is missing — including which dates it has no record for.